Table 1.
Characteristics of study participants
| Terms | Categories | Number of participants | |
|---|---|---|---|
| Area of expert | Pharmacology | 5 | |
| Clinical pharmacology | 1 | ||
| Molecular microbiology | 1 | ||
| Biotechnology and virology | 1 | ||
| Infectious diseases | 1 | ||
| Clinical pharmacy | 1 | ||
| Microbiology | 1 | ||
| Infectious disease epidemiology | 1 | ||
| Pharmaceutical chemistry | 1 | ||
| Pulmonary pediatrics and infectious diseases | 1 | ||
| Epidemiology and biostatistics | 1 | ||
| Zoonosis | 1 | ||
| Trans-boundary diseases | 1 | ||
| Domain of experiences | Preclinical trials plus others | 10 | |
| Clinical trials plus others | 3 | ||
| Both (preclinical and clinical trials) plus others | 4 | ||
| Years of research experiences | 5–20 Years | 12 | |
| > 20 Years | 5 | ||
| Role as a PI in research | Preclinical | 1–6 projects | 10 |
| 20–30 projects | 3 | ||
| Clinical trial | 1 project | 4 | |
| 5 projects | 2 | ||
|
Focus area in terms of diseases/ Pathogens/ Others |
Studied in preclinical studies for both animal and human |
African horse sickness, Anthrax, Antiinfertility, Antinflammation, Antipyretic, Antispasmodic, Asthma, Diabetic mellitus, E.coli, Fasciola hepatica, Fowl cholera, Pasteurellosis, Leishmania, Schistosomiasis, Fowl typhoid, Haemonchus contortus, Helminthes, Hypertension, Leishmania, Liver related diseases, Malaria, New castle disease, Infectious bursal disease, Histoplasma, Noncommunicable Neurodegenerative diseases, Phytogenics, Rabies, Relapsing fever, Rota virus, S.aureus, Salmonella, Trypanosomiasis, Tuberculosis |
- |
| Studied in clinical trial | Cervical cancer, Cholera, Diabetic mellitus, Helminthes, Hepatitis B, HIV, Malaria, Meningitis, Tuberculosis, Visceral leishmaniasis | - | |
| Phase of study (Note: one person can conduct many studies at each phase) | Number of studies | ||
| Phase 1 | 5, of them 1 waiting for approval | ||
| Phase 2 | 3 | ||
| Phase 3 | 4,of them 1 waiting for approval | ||
| Phase 4 | 1 | ||
| Not applicable (For preclinical research and vaccine trials) | 11 | ||
| Type of trial for clinical trial and preclinical studies | Drug | 7 | |
| Vaccine | 7 | ||
| Diagnostic tools | 2 | ||
| Pharmaceuticals dosage formulations on traditional medicinal plants | 2 | ||
| Medicinal plants | 8 | ||